Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vitamins01:30

Vitamins

864
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
864
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

236
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
236
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

51
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
51
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

128
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
128

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary tract infection in the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Pitfalls in the Serologic Diagnosis of Maternal Syphilis: A Case Series.

Sexually transmitted diseases·2025
Same author

Blood cultures and predicting positivity in extremely preterm infants admitted to an outborn level IV NICU.

BMC pediatrics·2025
Same author

Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study.

The Journal of infectious diseases·2025
Same author

Role of Viral Codetections in Young Children With Respiratory Syncytial Virus Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults' responses.

Nature communications·2025

Related Experiment Video

Updated: Aug 12, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

11.6K

Neonatologists and vitamin K hesitancy.

Timothy P Rogers1, Omid Fathi1, Pablo J Sánchez2,3

  • 1Department of Pediatrics, Division of Neonatology, Nationwide Children's Hospital, Center for Perinatal Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH, 43205, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|January 27, 2023
PubMed
Summary

Vitamin K Deficiency Bleeding (VKDB) is preventable with a vitamin K shot at birth. Addressing parental concerns about this vital newborn prophylaxis is crucial to prevent serious bleeding risks.

More Related Videos

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

59.1K
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

2.3K

Related Experiment Videos

Last Updated: Aug 12, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

11.6K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

59.1K
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

2.3K

Area of Science:

  • Neonatal Health
  • Pediatric Public Health

Background:

  • Hemorrhagic disease of the newborn, now called Vitamin K Deficiency Bleeding (VKDB), historically caused significant infant illness and death.
  • Routine vitamin K prophylaxis at birth, recommended since 1961, has dramatically reduced VKDB incidence.

Purpose of the Study:

  • To examine parental hesitancy towards newborn vitamin K prophylaxis.
  • To explore strategies for healthcare professionals to address parental concerns and ensure VKDB prevention.

Main Methods:

  • Review of current trends in parental refusal of newborn interventions.
  • Analysis of parental concerns regarding vitamin K injections, preservatives, and personal beliefs.
  • Discussion of shared decision-making models and educational interventions.

Main Results:

  • A growing number of parents express reluctance to administer vitamin K to newborns.
  • Concerns cited include injection safety, medication preservatives, and personal/religious beliefs.
  • Refusal of vitamin K is often linked to opting out of other essential newborn care and vaccinations.

Conclusions:

  • Parental hesitancy towards vitamin K prophylaxis poses a public health risk, potentially leading to a resurgence of preventable infant bleeding disorders.
  • Effective communication and shared decision-making are essential for healthcare providers to overcome parental concerns and maintain high rates of vitamin K administration.
  • Addressing distrust in the medical establishment is key to ensuring optimal newborn health outcomes and preventing VKDB.